Endovascular Treatment of Aortobronchial Fistula Secondary to Coronary Artery Bypass Graft (CABG)

Aortobronchial fistula (abf) is a rare and late complication of cardiac surgery. if untreated, mortality rate is approximately 100% secondary to exsanguinations haemoptysis. early diagnosis and treatment are essential for successful management. open surgical repair is associated with high morbidity and mortality rate, ranging from 25% to 41%. endovascular treatments of abf is a less invasive treatment modality and have become an important alternative to open surgical intervention in aortic pathologies. we present a case of abf that successfully is managed by endovascular approach.